Nerve growth factor (NGF) expression in correlation with severity of pruritus in cirrhotic patients

NADA, ESSAMELDIN Abd El-Aziz; Assaf, Hanan Abd El Rady; El Sharkawy, Reham Ezz El-Dawla; Zaghloul, Amr Mohamed; Abd El Meged, Marwa Mohamed; Abd  El Wahed, Mahmoud Rezk; Ahmed, Asmaa Mahmoud

doi:10.21608/smj.2018.42251

Nerve growth factor (NGF) expression in correlation with severity of pruritus in cirrhotic patients

Document Type : Original Article

Authors

¹ DERMATOLOGY, Venereology and Andrology, Faculty of Medicine , sohag university.

² Department of Dermatology, Venereology and Andrology, Sohag Faculty of Medicine, Sohag University.

³ Departments of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University.

⁴ Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University.

⁵ Department of pathology, Assuit Faculty of Medicine, Assuit University.

10.21608/smj.2018.42251

Abstract

Background:Hepatic pruritus is a very common symptom among different chronic liver diseases, particularly in those related to cholestasis. Its prevalence is variable among liver diseases, ranging from 5% in chronic hepatitis C virus infection to 70% in primary biliary cirrhosis. Its etiopathogenesis remains poorly understood.Nerve growth factor (NGF) is a member of neurotrophins. many studies clearly demonstrate their role in pruritus. Nerve growth factor (NGF) is overexpressed in prurigonodularis and its therapeutic administration is pruritogenic. In atopic dermatitis, NGF is released by keratinocytes, mast cells and fibroblasts and plasma levels of NGF are also elevated and correlate with disease activity.This study examines the hypothesis that expression of NGF protein is altered in cirrhotic patients with pruritus.
Patients and Methods: To test our hypothesis, we examined the expression patterns of NGF protein in cirrhotic patients with pruritus, cirrhotic patients without pruritus and corresponding healthy (control). skin biopsies (20 specimens each) were evaluated using immunoperoxidase staining techniques.
Results: We found variations between the skins of cirrhotic patients with and without pruritus and healthy skin. In healthy skin, the expression of NGF protein was strong (basal cell keratinocytes), moderate (spinouslayer), and weak or abscent (granular cell layer). In contrast, marked expression of NGF protein was observed in all layers of skin (total NGF epidermis and dermis) incirrhotic patients with pruritus in comparison with cirrhotic patients without pruritus and healthy control and this was statistically significant. NGF protein expression was strong (basal cell keratinocytes), moderate (spinous layer), and weak or abscent (granular cell layer). The expression of NGF protein was strong in the adnexal structures.
Conclusions: We report, for the first time, increased expression of NGF protein in the epidermal keratinocytes of cirrhotic patients with pruritus skin. Our findings suggest possible roles for this protienin pathophysiology of hepatic pruritus. The clinical ramifications of these observations mandate further investigations.

References

1- Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ(2009): American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology.;50(1):291-308 .

2- ones D(2012): Pathogenesis of cholestatic itch: old questions, new

answers, and future opportunities. Hepatology.;56(4):1194-6 .

3- Kremer AE, Feramisco J, Reeh PW, Beuers U, Oude Elferink RP(2014): Receptors, cells and circuits involved in pruritus of systemic

disorders. BiochimBiophysActa.; 1842(7):869-92.

4- Oude Elferink RP, Bolier R, Beuers UH(2015):Lysophosphatidic acid and signaling in sensory neurons. BiochimBiophysActa.; 1851(1):61-5.

5- Azevedo R, Takamatsu F, Kondo M, Ferraz M, Mattar R, Cestari S, SalzedasNetto A, Souza P, Pinto W, RezendeFilho F, Oliveira A (2017): Pruritus in cholestasis. Rev Soc Bras Clin Med.;15(1):61-7.

6- Raap U and Kapp A (2010): Neuroimmunological findings in allergic skin diseases. CurrOpin Allergy ClinImmunol 5:419–24

7- Pincelli C, Yaar M (1997): Nerve growth factor: its significance in cutaneous biology.JInvestigDermatolSympProc 2:61–8.

8- Teng K and Hempstead B (2004): Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol Life Sci.;61:35-48.

9- Zegarska B, Lelińska A, Tyrakowski T (2006). Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacol Rep.;58:13-21.

10- Nockher W and Renz H (2003):Neurotrophins in inflammatory lung diseases: modulators of cell differentiation and neuroimmune interactions. Cytokine Growth Factor Rev; 14: 559-78.

11-Suarez A, Feramisco J, Koo J, Steinhoff M (2012)Psychoneuroimmunology of Psychological Stress and Atopic Dermatitis: Pathophysiologic and Therapeutic Updates. Acta dermato- venereologica.;92(1):7-15

12- Adly M, Assaf H, Nada E, Soliman M, Hussein M (2006): Expression of nerve growth factor and its high-affinity receptor, tyrosine kinase Aproteins, in the human scalp skin. J CutanPathol; 33: 559–568 .

13- Dou Y, Hagstromer L, Emtestam L. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 2006; 298: 31-7.

14-Hodeib A, El-Samad Z, Hanafy H, El-Latief A, El-bendary A, Abu-Raya A: Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis. Indian J Dermatol 2010;55:135-9.

15- Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M (2002): Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol.; 147:71-9.

16- Schulte-Herbrüggen O, Floster-Holst R, von Elstermann M, Augustin M, Hellweg R: Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis. IntArch Allergy Immunol. 2007; 144 (3):211–216.

17- Levi-Montalcini R, Dal Toso R, Della Valle F, Skaper SD, Alberta L. Update of the NGF saga. J Neurol Sci. 1995; 130 (2):119–127.

18- Joachim R, Kuhlmei A, Dinh Q, Handjiski B, Fischer T, Peters E: Neuronal plasticity of the brain–skin connection stress-triggered upregulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med. 2007; 85 (12):1369–1378.